Not provided
Not provided
Not provided
Not provided
Not provided
inadequate recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Giant cell arteritis is the leading cause of vasculitis in the elderly. No work evaluates its impact on autonomy. At the diagnosis a gerontological evaluation will be carried out including the scores ADL, iADL, MNA, SF 36, SPPB, FRIED and GDS. A monthly telephone reassessment will collect ADL and iADL. The end-of-study consultation at M12, conducted by a geriatrician, will have the same scores as at M0. This will make it possible to evaluate the difference in the functional autonomy score between M0 and M12 in the elderly with ACG.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| assessment by questionnaire |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment by questionnaire | Other | At diagnosis a gerontological evaluation will be carried out including the following tests: ADL, iADL, MNA, SF 36, SPPB, FRIED criteria and GDS. The set of scales and scores of the procedure is commonly used in geriatrics to assess the fragility of the patient. A monthly telephone reassessment conducted by an ARC will collect ADL and iADL from the first month to the eleventh month. The end-of-study consultation will be conducted by a geriatrician at the 12th month and will include the following tests: ADL, iADL, MNA, SF 36, the SPPB, the criteria of FRIED and the GDS |
| Measure | Description | Time Frame |
|---|---|---|
| Activities of Daily Living (ADL) | Compare score between Month 0 and Month 12. The scale is evaluated from 0 (dependence) to 6 (autonomy). | Month 12 |
| Measure | Description | Time Frame |
|---|---|---|
| Activities of Daily Living (ADL) | Compare the evolution every month at M0 and every month up to Month 11 The scale is evaluated from 0 (dependence) to 6 (autonomy). | Month 11 |
| Measure | Description | Time Frame |
|---|---|---|
| Instrumental Activities of Daily Living (iADL) | Compare the evolution every month at Month 0 and every month up to Month 12 The scale is evaluated from 0 (dependence) to 8 (autonomy). | Month 12 |
| Mini Nutritional Assessment (MNA) |
Inclusion Criteria:
Age greater than or equal to 65 years with at least 2 comorbidities * present, or age greater than or equal to 75 years
Diagnosis of ACG meeting the diagnostic criteria of ACG 1990 ACR
Exclusion Criteria:
Not provided
Not provided
Not provided
patient with giant cell arteritis
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Limoges | 87042 | France |
Not provided
| ID | Term |
|---|---|
| D013700 | Giant Cell Arteritis |
| ID | Term |
|---|---|
| D020293 | Vasculitis, Central Nervous System |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D002561 | Cerebrovascular Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Compare score between Month 0 and Month 12 The scale is evaluated from 0 (poor nutritional status) to 30 (correct)
| Month 12 |
| The Short Form Health Survey (SF-36) : Physical score | Compare score between Month 0 and Month 12 The scale is evaluated from 13,6 (poor physical condition) to 61.9 (good physical condition) | Month 12 |
| The Short Form Health Survey (SF-36) : Psychic score | Compare score between Month 0 and Month 12 The scale is evaluated from 15.6 (poor psychic condition) to 70 (good physical condition) | Month 12 |
| Short Physical Performans Battery (SPPB) | compare score between Month 0 and Month 12 The scale is evaluated from 0 (poor performance) to 12 (high performance) | Month 12 |
| fragility criteria questionnaire (Fried) | compare score between Month 0 and Month 12 The scale is evaluated from 0 (robust) to 5 (fragile) | Month 12 |
| Geriatric Depression Scale (GDS) | compare score between Month 0 and Month 12 The scale is evaluated from 0 (normal) to 30 (severe depression) | Month 12 |
| The cumulative dose of corticosteroids and autonony loss | Month 12 |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001167 | Arteritis |
| D014657 | Vasculitis |
| D017445 | Skin Diseases, Vascular |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |